Aarey Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE198H01019
  • NSEID: AAREYDRUGS
  • BSEID: 524412
INR
115.75
4.1 (3.67%)
BSENSE

Nov 20

BSE+NSE Vol: 2.68 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 933527,
    "name": "Aarey Drugs",
    "stock_name": "Aarey Drugs",
    "full_name": "Aarey Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/aarey-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "115.75",
    "chg": 4.1,
    "chgp": "3.67%",
    "dir": 1,
    "prev_price": "111.65",
    "mcapval": "373.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524412,
    "symbol": "AAREYDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE198H01019",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "2.68 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/aarey-drugs-933527-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd’s Volatile Week: 0.26% Gain Amid Circuit Breaker and Valuation Shifts",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltds-volatile-week-026-gain-amid-circuit-breaker-and-valuation-shifts-4270491",
        "imagepath": "",
        "date": "2026-11-21 15:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Stock opens at Rs.110.10, declines sharply</p>\n                    <p><strong>17 Nov:</strong> Hits lower circuit amid heavy selling pressure</p>\n                    <p><strong>18 Nov:</strong> Valuation shifts signal changing price attractiveness</p>\n                    <p><strong>20 Nov:</strong> Week closes at Rs.115.75, modest weekly gain</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.110.10</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.115.75</div><div clas..."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Changing Price Attractiveness",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-valuation-shifts-signal-changing-price-attractiveness-4266090",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AareyDrugsPharm_valuationdot_4266090.png",
        "date": "2026-11-18 08:05:24",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid a backdrop of strong stock returns and mixed financial metrics, prompting investors to reassess the company’s price attractiveness relative to its historical averages and peer group."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-hold-4265132",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AareyDrugsPharm_mojoScore_4265132.png",
        "date": "2026-11-17 10:11:07",
        "description": "Aarey Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Locks at Lower Circuit With 4.61% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4265078",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AareyDrugsPharm_stocks_hitting_lower_circuit_4265078.png",
        "date": "2026-11-17 10:00:28",
        "description": "At Rs 106.00, sellers were still queuing — but there were no buyers willing to take the other side. Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit of 5% on 17 Nov 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a thinly traded micro-cap stock."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 4.26% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4259553",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AareyDrugsPharm_stocks_hitting_upper_circuit_4259553.png",
        "date": "2026-11-12 14:00:10",
        "description": "At Rs 113.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 4.26% on 11 Nov 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Declines 0.66% Despite Sector Gains: 5 Key Factors Driving the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-declines-066-despite-sector-gains-5-key-factors-driving-the-week-4245823",
        "imagepath": "",
        "date": "2026-10-31 15:00:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock hits lower circuit amid heavy selling pressure</p>\n                    <p><strong>29 Oct:</strong> Valuation grade upgraded to attractive despite Sell rating</p>\n                    <p><strong>30 Oct:</strong> Week closes at Rs.105.25 (-0.66%) versus Sensex +2.12%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.105.95</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.105.25</div><div class=\"stat-change negative\">-0.66%</div></div>\n                    <div class..."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-sell-4238765",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AareyDrugsPharm_mojoScore_4238765.png",
        "date": "2026-10-26 10:10:14",
        "description": "Aarey Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 15 August 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 26 October 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4238226",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AareyDrugsPharm_valuationdot_4238226.png",
        "date": "2026-10-26 08:01:36",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating despite a recent downgrade in its overall Mojo Grade to Sell. This article analyses the evolving price-to-earnings (P/E) and price-to-book value (P/BV) ratios in the context of historical trends and peer comparisons, offering investors a comprehensive view of the stock’s current price attractiveness within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Falls 6.16%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-falls-616-3-key-factors-driving-the-weekly-decline-4237261",
        "imagepath": "",
        "date": "2026-10-24 15:00:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>19 Oct:</strong> New 52-week high at Rs.116.8</p>\n                    <p><strong>21 Oct:</strong> All-time high reached at Rs.118.9</p>\n                    <p><strong>23 Oct:</strong> Hits lower circuit amid heavy selling pressure</p>\n                    <p><strong>23 Oct:</strong> Week closes at Rs.105.95 (-6.16%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.112.90</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.105.95</div><div class=\"stat-change negative\">-6.16%</div></div>\n ..."
      }
    ],
    "total": 85,
    "sid": "933527",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/aarey-drugs-pharmaceuticals-933527"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Nov-2026",
      "details": "Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 the company has published and extract of statement of unaudited standalone Financial Results for the Second quarter and Half Year ended on September 30 2026 which have been considered approved and taken on record by the Board of Directors at their meeting held on Saturday 14th November 2026. The said financial results have been published in Active Times (English Newspaper) edition dated 17/11/2026 & in Mumbai lakshadeep (Marathi newspaper) edition dated 16/11/2026.",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation And Variation For The Quarter Ended September 30 2026",
      "datetime": "14-Nov-2026",
      "details": "Statement of deviation and variation for the quarter ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 14 2026",
      "datetime": "14-Nov-2026",
      "details": "1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial Results for the second quarter & half year ended on 30th September 2026 along with the Limited Review Report MD/CFO certification.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 13 Dec 18",
          "dt": "2018-12-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 25 Jun 12",
          "dt": "2012-06-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>2:1</strong> rights issue, ex-date: 19 Jan 12",
          "dt": "2012-01-19",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Nov-2026 | Source : BSE

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 the company has published and extract of statement of unaudited standalone Financial Results for the Second quarter and Half Year ended on September 30 2026 which have been considered approved and taken on record by the Board of Directors at their meeting held on Saturday 14th November 2026. The said financial results have been published in Active Times (English Newspaper) edition dated 17/11/2026 & in Mumbai lakshadeep (Marathi newspaper) edition dated 16/11/2026.

Statement Of Deviation And Variation For The Quarter Ended September 30 2026

14-Nov-2026 | Source : BSE

Statement of deviation and variation for the quarter ended September 30 2026

Board Meeting Outcome for Outcome Of Board Meeting Held On November 14 2026

14-Nov-2026 | Source : BSE

1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial Results for the second quarter & half year ended on 30th September 2026 along with the Limited Review Report MD/CFO certification.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Aarey Drugs & Pharmaceuticals Ltd has declared 1% dividend, ex-date: 13 Dec 18

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Aarey Drugs & Pharmaceuticals Ltd has announced 1:5 bonus issue, ex-date: 25 Jun 12

stock-summary
RIGHTS

Aarey Drugs & Pharmaceuticals Ltd has announced 2:1 rights issue, ex-date: 19 Jan 12